Best practice documents are intended for use by health care workers and facilities/organizations providing health care including hospitals, long-term care facilities and community-based health care organizations. Recommendations in best practice documents are developed through reviews of literature and consultations with experts in infectious disease, surveillance, communicable disease and immunization.
This document sets out interim best practices to address a novel respiratory infection, for all health care settings, prior to specific guidance being issued. It takes a precautionary approach that combines Airborne Precautions and Droplet/Contact Precautions when the aetiology agent or epidemiology is not yet known, and the morbidity and mortality are presumed to be severe.
This document provides evidence-based infection prevention and control (IPAC) recommendations for perinatology. It was developed for those providing perinatal care at all levels (primary, secondary, tertiary), including physicians (neonatologists, obstetricians, family physicians, pediatricians); nurses (obstetrical, neonatal, pediatric, public health); midwives; lactation consultants; as well as infection control professionals (ICPs).
Note: This document was updated in February 2015 to reflect a regulatory change made to the Ontario Reportable Diseases List - Herpes simplex active disease in newborn is no longer reportable as of December 4, 2013.
This best practice document is intended as a guide for infection control professionals in acute and long-term care, to ensure that the critical elements and methods of surveillance for health care-associated infections (HAIs) are incorporated into their practice. It provides guidelines for each of the building blocks of the surveillance system including planning, data collection, interpretation, analysis and communication, to inform infection prevention and control practices that will result in effective surveillance in hospitals and long-term care homes.
Note: This document was made available in July 2014 with updates to case definitions, mandatory reporting requirements in Ontario, and information about electronic surveillance systems and the use of surveillance information.
Carbapenemase-producing Enterobacteriaceae (CPE) Surveillance Reports
This document was developed to provide best practices for the performance of hand hygiene in health care settings across the continuum of care. This includes, but is not limited to, acute care, complex continuing care, rehabilitation facilities, long-term care homes, chronic care, pre-hospital care and home health care.
This best practice document was developed in collaboration with the College of Physicians and Surgeons of Ontario to support those working in clinical office settings to minimize the risk of infection transmission in office-based practice.
This best practice document is intended for health care providers to ensure that the critical elements and methods of decontamination, disinfection and sterilization are incorporated into health care facility procedures. The document describes essential elements and methods in the safe handling, monitoring and auditing, transportation and biological decontamination of contaminated medical equipment/devices.
This document outlines the practice of Routine Practices and Additional Precautions (RP/AP) in health care settings across the continuum of care including, but not limited to, pre-hospital care, acute care, complex continuing care, rehabilitation facilities, long-term care, chronic care, ambulatory care and home health care.
Note: Please be advised that the Ministry of Health and Long-Term Care is in the process of reviewing influenza immunization for health care providers in acute care facilities, as well as other strategies to prevent and control nosocomial influenza.
This best practice document deals with cleaning and disinfection of the physical environment in health care as they relate to the prevention and control of infections. It is targeted to those who have a role in the management of cleaning/housekeeping services for the health care setting. This includes administrators, supervisors of ES departments, infection prevention and control professionals, supervisors of construction/maintenance projects and public health investigators. This document is current as of May 2012 and is currently under review.
The purpose of this document is to provide recommendations for specific activities for IPAC programs across the continuum of health care delivery in Ontario and for the adequate and appropriate resource allocation for IPAC programs across the continuum of health care delivery. The document was developed for senior administration, administrators in local health integration networks, medical officers of health and others in a management role.
This document provides best practice recommendations meant to support public health staff in Sexually Transmitted Infection (STI) programs in Ontario Public Health Units (PHUs). The focus of this document is on case management of persons diagnosed with sexually transmitted infections and their sexual contacts. Issues related to modes of testing (for example anonymous and point of care testing for HIV) are beyond the scope of this document.
This document is current as of April 2009 and is currently under review.
This information requires knowledgeable interpretation and is intended primarily for use by health care workers and facilities/organizations providing health care including hospitals, long-term care facilities, community-based health care service providers and pre-hospital emergency services.
This document is intended to assist health care workers in acute care settings in the identification and immediate management of patients who present with severe acute respiratory infection that may be due to MERS-CoV. It is a supplement to existing PIDAC documents including Routine Practices and Additional Precautions in all Health Care Settings and Annex B: Prevention of Transmission of Acute Respiratory Infection in all Health Care Settings. It contains links to MERS-COV guidance from the Ontario Ministry of Health and Long-Term Care at www.ontario.ca/novelcoronavirus, the Public Health Agency of Canada, the World Health Organization and other important sources.
Note: This document was revised in May 2016 to update the list of countries affected by MERS-CoV and information related to morbidity and mortality, and mode of transmission.
This document provides highlights of the 2015 update on the Recommended Human Papillomavirus (HPV) Vaccine Immunization Schedule by the National Advisory Committee on Immunization (NACI), within the context of Ontario’s HPV vaccination program and the vaccines’ product monographs, in order to provide a PIDAC-I position on two-dose schedules.
Recommendations for Human Papillomavirus (HPV) Vaccination (June 2012)
This document provides an overview of the options for consideration for the HPV vaccination program. It also provides a summary of the comparative cost effectiveness of the HPV vaccines.
Recommendations for Human Papillomavirus (HPV) Vaccine Schedule (2015)
This document, developed by the Provincial Infectious Diseases Advisory Committee on Immunization, provides a brief review of the common guidance statement prepared by the National Advisory Committee on Immunization (NACI) and the Meningococcal B Pilot Project Task Group (MBPPTG) on the use of the Multicomponent Meningococcal B (4CMenB) vaccine, reviews data from an Ontario perspective and outlines options for the Ontario Ministry of Health and Long-Term Care (MOHLTC) to consider with respect to 4CMenB immunization program planning.
This document is intended for health care providers involved in the case and contact management of invasive Group A (iGAS) Streptococcal disease. It provides recommendations for determining evidence of severity in iGAS cases, contact management, and screening in long-term care facilities.
This document, developed by the Provincial Infectious Diseases Advisory Committee on Communicable Diseases, is intended to assist public health unit staff - including Medical Officers of Health, Associate Medical Officers of Health, and program managers - by providing them with current recommendations for responding to hepatitis C.
This document, developed by the Provincial Infectious Diseases Advisory Committee on Immunization, is intended to assist public health units address queries relating to the Hepatitis A chapter of the Ministry of Health and Long-Term Care’s 2009 Infectious Diseases Protocol, which provides case and contact management advice for reportable diseases in Ontario.
This document provides evidence-based scientific and technical advice from Provincial Infectious Diseases Advisory Committee on Immunization (PIDAC-I) regarding options for consideration with respect to the use of herpes zoster vaccine in Ontario.
The Syndromic Surveillance Discussion Paper describes sources of syndromic surveillance data, along with their applications and attributes, and it summarizes the published evidence related to their effectiveness as part of a public health surveillance system.
In this report, the use of such data is described in the context of infectious diseases surveillance only. The report also outlines relevant characteristics of syndromic surveillance systems, such as timeliness and automation, as they inform recommendations for implementation in Ontario.
This document provides a summary of the review the evidence pertaining to pertussis vaccination in adults, including information on waning immunity, and to make recommendations on its use in Ontario.
This document provides a detailed summary of the scientific review of published literature on the control of vancomycin-resistant enterococci (VRE) up to July 2012. A detailed summary of this review is provided in this document. Based on the evidence reviewed, Provincial Infectious Diseases Advisory Committee on Infection Prevention and Control (PIDAC-IPC) continues to recommend VRE admission screening, surveillance and control measures as outlined in PIDAC’s Routine Practices and Additional Precautions in All Health Care Settings, Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs).